FDA NDC Directory · JSON-LD · Markdown
NDC 67877-772 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SOLUTION
| Labeler / Manufacturer | Ascend Laboratories, LLC |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA216635 |
| Dosage form / route | POWDER, FOR SOLUTION · ORAL |
| Active ingredients | DICLOFENAC POTASSIUM (50 mg/1) |
| Marketing started | 20221024 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).